Cytolon is a Berlin-based company that has developed a proprietary, patent-pending, internet-based matching platform termed CordMatch®. This platform is unique, as it integrates product search and matching, selection and logistics plus billing and follow-up. The platform was especially designed to support the first existing personalized medicine market: the treatment of leukemia patients with hematopoietic stem cells. CordMatch® accurately matches the patient's genetic or molecular data with the characteristics of a given product to achieve the best possible therapeutic effect. Additionally, the emerging markets of personalized medicine need to match appropriate products to tens of thousands of patient cases in parallel at any time. Cytolon's enabling technology fulfills this central need of personalized medicine.